(L to R): Members of the U.S. Neurology Internal Engine Stephanie Hunter-Banks, Jim Hlavenka, Brad Chapman, Trenton Merideth, Tonja Pitts

UCB’s U.S. Neurology team won a 2019 EyeForPharma award last night in the “Most Promising Agile Transformation” category, which recognizes an experimental initiative that has the potential to disrupt the status quo. The award was presented for the team’s Internal Engine transformation, fulfilling the award criteria of showing agility through rapid creation of a service that touched real customers before being refined and assessed through smart measurement.

At UCB, our approach to innovation is designed around the patient and their individual experience. Every day, Chris Protos, Solution Enablement Lead, wakes up and thinks about ways we can continue to keep patients at the heart of everything we do. Hear more from Chris about how we’re addressing gaps in patient care through our patient-driven approach to innovation by watching the video below.

As UCB attends the 2019 American Epilepsy Society meeting in Baltimore, Maryland this week, Mike Davis, Head of Neurology in the U.S., talks about the long way to go in managing epilepsy, and how UCB is committed to closing this gap by bringing new solutions to market. Read the article on LinkedIn.

At just one day old, Spencer, born in Greenville, South Carolina, had his first seizure, a sudden, uncontrolled electrical disturbance in the brain that usually causes a change in behavior.^1,2

UCB's Denelle Waynick, VP, Legal Affairs (U.S.), U.S. General Counsel and Global Head, Enterprise Risk Management, leads by example by being true to herself to encourage others to do so too. Read more from Denelle on why by being authentic to yourself, you become stronger as an individual, leader, and employee. Read the full article on LinkedIn.

UCB researchers like Jessica Williamson, PhD, come to work driven by a singular purpose – to create value for people living with severe disease. That’s because patients depend on the important work of scientific research to discover new medical innovations that will help them achieve their goals. Read more from Dr. Williamson about why she's passionate about innovating for patients and UCB's growing research presence in the greater Boston area.

At UCB, we keep patients at the center - inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We have a rich heritage in epilepsy, and today, we’re shining a spotlight on seizure clusters, which can affect people with uncontrolled epilepsy, to help spread awareness. Check out the full infographic below.

At UCB, we keep patients at the center - inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We have a rich heritage in epilepsy, and today, we’re shining a spotlight on seizure clusters, which can affect people with uncontrolled epilepsy, to help spread awareness.

Learn more about living with non-radiographic axial spondyloarthritis (nr-axSpA) from Chelsea, who recently shared her story.

At UCB, we keep patients at the center of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. Read more from UCB's CEO and Chairman of the Executive Committee, Jean-Christophe Tellier, about why it's time to come together across all healthcare stakeholders to deliver more for patients.